Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19Erik H Vogelzang, Lucas M. Fleuren, Floris C. Loeff et al.|The Journal of Immunology|2020Cited by 85
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosisLiza M. Y. Gelissen, Zoé L. E. van Kempen, Luuk C van Rooij et al.|Journal of Neurology Neurosurgery & Psychiatry|2025Cited by 1